Tanya K Marvi1, William B Stubblefield2, Benjamin F Tillman3, Mark W Tenforde4, Manish M Patel4, Christopher J Lindsell5, Wesley H Self2,6, Carlos G Grijalva7, Todd W Rice6,8. 1. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. 2. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN. 3. Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. 4. COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA. 5. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. 6. Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center, Nashville, TN. 7. Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN. 8. Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Abstract
To test the hypothesis that relatively lower clot strength on thromboelastography maximum amplitude (MA) is associated with development of venous thromboembolism (VTE) in critically ill patients with COVID-19. DESIGN: Prospective, observational cohort study. SETTING: Tertiary care, academic medical center in Nashville, TN. PATIENTS: Patients with acute respiratory failure from COVID-19 pneumonia admitted to the adult medical ICU without known VTE at enrollment. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Ninety-eight consecutive critically ill adults with laboratory-confirmed COVID-19 were enrolled. Thromboelastography parameters and conventional coagulation parameters were measured on days 0 (within 48 hr of ICU admission), 3, 5, and 7 after enrollment. The primary outcome was diagnosis of VTE with confirmed deep venous thrombosis and/or pulmonary embolism by clinical imaging or autopsy. Twenty-six patients developed a VTE. Multivariable regression controlling for antiplatelet exposure and anticoagulation dose with death as a competing risk found that lower MA was associated with increased risk of VTE. Each 1 mm increase in enrollment and peak MA was associated with an 8% and 14% decrease in the risk of VTE, respectively (enrollment MA: subdistribution hazard ratio [SHR], 0.92; 95% CI, 0.87-0.97; p = 0.003 and peak MA: SHR, 0.86; 95% CI, 0.81-0.91; p < 0.001). Lower enrollment platelet counts and fibrinogen levels were also associated with increased risk of VTE (p = 0.002 and p = 0.01, respectively). Platelet count and fibrinogen level were positively associated with MA (multivariable model: adjusted R 2 = 0.51; p < 0.001). CONCLUSIONS: When controlling for the competing risk of death, lower enrollment and peak MA were associated with increased risk of VTE. Lower platelet counts and fibrinogen levels at enrollment were associated with increased risk of VTE. The association of diminished MA, platelet counts, and fibrinogen with VTE may suggest a relative consumptive coagulopathy in critically ill patients with COVID-19.
To test the hypothesis that relatively lower clot strength on thromboelastography maximum amplitude (MA) is associated with development of venous thromboembolism (VTE) in critically ill patients with COVID-19. DESIGN: Prospective, observational cohort study. SETTING: Tertiary care, academic medical center in Nashville, TN. PATIENTS: Patients with acute respiratory failure from COVID-19 pneumonia admitted to the adult medical ICU without known VTE at enrollment. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Ninety-eight consecutive critically ill adults with laboratory-confirmed COVID-19 were enrolled. Thromboelastography parameters and conventional coagulation parameters were measured on days 0 (within 48 hr of ICU admission), 3, 5, and 7 after enrollment. The primary outcome was diagnosis of VTE with confirmed deep venous thrombosis and/or pulmonary embolism by clinical imaging or autopsy. Twenty-six patients developed a VTE. Multivariable regression controlling for antiplatelet exposure and anticoagulation dose with death as a competing risk found that lower MA was associated with increased risk of VTE. Each 1 mm increase in enrollment and peak MA was associated with an 8% and 14% decrease in the risk of VTE, respectively (enrollment MA: subdistribution hazard ratio [SHR], 0.92; 95% CI, 0.87-0.97; p = 0.003 and peak MA: SHR, 0.86; 95% CI, 0.81-0.91; p < 0.001). Lower enrollment platelet counts and fibrinogen levels were also associated with increased risk of VTE (p = 0.002 and p = 0.01, respectively). Platelet count and fibrinogen level were positively associated with MA (multivariable model: adjusted R 2 = 0.51; p < 0.001). CONCLUSIONS: When controlling for the competing risk of death, lower enrollment and peak MA were associated with increased risk of VTE. Lower platelet counts and fibrinogen levels at enrollment were associated with increased risk of VTE. The association of diminished MA, platelet counts, and fibrinogen with VTE may suggest a relative consumptive coagulopathy in critically ill patients with COVID-19.
Authors: Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda Journal: J Biomed Inform Date: 2019-05-09 Impact factor: 6.317
Authors: Abhimanyu Chandel; Saloni Patolia; Mary Looby; Najeebah Bade; Vikramjit Khangoora; Christopher S King Journal: J Intensive Care Med Date: 2021-03-01 Impact factor: 3.510
Authors: Thomas K Maatman; Farid Jalali; Cyrus Feizpour; Anthony Douglas; Sean P McGuire; Gabriel Kinnaman; Jennifer L Hartwell; Benjamin T Maatman; Rolf P Kreutz; Rajat Kapoor; Omar Rahman; Nicholas J Zyromski; Ashley D Meagher Journal: Crit Care Med Date: 2020-09 Impact factor: 9.296
Authors: Ewan C Goligher; Charlotte A Bradbury; Bryan J McVerry; Patrick R Lawler; Jeffrey S Berger; Michelle N Gong; Marc Carrier; Harmony R Reynolds; Anand Kumar; Alexis F Turgeon; Lucy Z Kornblith; Susan R Kahn; John C Marshall; Keri S Kim; Brett L Houston; Lennie P G Derde; Mary Cushman; Tobias Tritschler; Derek C Angus; Lucas C Godoy; Zoe McQuilten; Bridget-Anne Kirwan; Michael E Farkouh; Maria M Brooks; Roger J Lewis; Lindsay R Berry; Elizabeth Lorenzi; Anthony C Gordon; Tania Ahuja; Farah Al-Beidh; Djillali Annane; Yaseen M Arabi; Diptesh Aryal; Lisa Baumann Kreuziger; Abi Beane; Zahra Bhimani; Shailesh Bihari; Henny H Billett; Lindsay Bond; Marc Bonten; Frank Brunkhorst; Meredith Buxton; Adrian Buzgau; Lana A Castellucci; Sweta Chekuri; Jen-Ting Chen; Allen C Cheng; Tamta Chkhikvadze; Benjamin Coiffard; Aira Contreras; Todd W Costantini; Sophie de Brouwer; Michelle A Detry; Abhijit Duggal; Vladimír Džavík; Mark B Effron; Heather F Eng; Jorge Escobedo; Lise J Estcourt; Brendan M Everett; Dean A Fergusson; Mark Fitzgerald; Robert A Fowler; Joshua D Froess; Zhuxuan Fu; Jean P Galanaud; Benjamin T Galen; Sheetal Gandotra; Timothy D Girard; Andrew L Goodman; Herman Goossens; Cameron Green; Yonatan Y Greenstein; Peter L Gross; Rashan Haniffa; Sheila M Hegde; Carolyn M Hendrickson; Alisa M Higgins; Alexander A Hindenburg; Aluko A Hope; James M Horowitz; Christopher M Horvat; David T Huang; Kristin Hudock; Beverley J Hunt; Mansoor Husain; Robert C Hyzy; Jeffrey R Jacobson; Devachandran Jayakumar; Norma M Keller; Akram Khan; Yuri Kim; Andrei Kindzelski; Andrew J King; M Margaret Knudson; Aaron E Kornblith; Matthew E Kutcher; Michael A Laffan; Francois Lamontagne; Grégoire Le Gal; Christine M Leeper; Eric S Leifer; George Lim; Felipe Gallego Lima; Kelsey Linstrum; Edward Litton; Jose Lopez-Sendon; Sylvain A Lother; Nicole Marten; Andréa Saud Marinez; Mary Martinez; Eduardo Mateos Garcia; Stavroula Mavromichalis; Daniel F McAuley; Emily G McDonald; Anna McGlothlin; Shay P McGuinness; Saskia Middeldorp; Stephanie K Montgomery; Paul R Mouncey; Srinivas Murthy; Girish B Nair; Rahul Nair; Alistair D Nichol; Jose C Nicolau; Brenda Nunez-Garcia; John J Park; Pauline K Park; Rachael L Parke; Jane C Parker; Sam Parnia; Jonathan D Paul; Mauricio Pompilio; John G Quigley; Robert S Rosenson; Natalia S Rost; Kathryn Rowan; Fernanda O Santos; Marlene Santos; Mayler O Santos; Lewis Satterwhite; Christina T Saunders; Jake Schreiber; Roger E G Schutgens; Christopher W Seymour; Deborah M Siegal; Delcio G Silva; Aneesh B Singhal; Arthur S Slutsky; Dayna Solvason; Simon J Stanworth; Anne M Turner; Wilma van Bentum-Puijk; Frank L van de Veerdonk; Sean van Diepen; Gloria Vazquez-Grande; Lana Wahid; Vanessa Wareham; R Jay Widmer; Jennifer G Wilson; Eugene Yuriditsky; Yongqi Zhong; Scott M Berry; Colin J McArthur; Matthew D Neal; Judith S Hochman; Steven A Webb; Ryan Zarychanski Journal: N Engl J Med Date: 2021-08-04 Impact factor: 176.079